Compare SRI & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRI | WHWK |
|---|---|---|
| Founded | 1965 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.1M | 213.2M |
| IPO Year | 1997 | 2017 |
| Metric | SRI | WHWK |
|---|---|---|
| Price | $6.22 | $3.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $7.71 |
| AVG Volume (30 Days) | 155.1K | ★ 306.8K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 86.02 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $824,444,000.00 | $7,145,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.90 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.46 | N/A |
| 52 Week Low | $4.60 | $1.97 |
| 52 Week High | $9.71 | $5.50 |
| Indicator | SRI | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 29.33 | 22.83 |
| Support Level | $6.14 | $2.46 |
| Resistance Level | $7.51 | $3.88 |
| Average True Range (ATR) | 0.22 | 0.16 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 4.40 | 2.98 |
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company generates key revenue from the United States.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.